Why TG Therapeutics Stock Is Crashing Today - Yahoo

Aug 1, 2023 · Shares of TG Therapeutics (NASDAQ: TGTX) were crashing 50.4% lower as of 11:12 a.m. ET on Tuesday. Multiple sclerosis (MS) drug Briumvi, which launched in the U.S. in …

4%
OFF

Why TG Therapeutics Stock Is Crashing Today - Yahoo

2 weeks from now

Aug 1, 2023 · Shares of TG Therapeutics (NASDAQ: TGTX) were crashing 50.4% lower as of 11:12 a.m. ET on Tuesday. Multiple sclerosis (MS) drug Briumvi, which launched in the U.S. in …

yahoo.com

82%
OFF

After Plunging -9.82% In 4 Weeks, Here's Why The Trend

2 weeks from now

Apr 30, 2024 · TG Therapeutics (TGTX) has been on a downward spiral lately with significant selling pressure. After declining 9.8% over the past four weeks, the stock looks well positioned …

yahoo.com

9%
OFF

Why TGTX Stock Is Rallying Today - Yahoo Finance

2 weeks from now

21 hours ago · The shares of drug maker TG Therapeutics (TGTX) are climbing 9% today after the firm preannounced higher-than-expected 2024 revenue from its multiple sclerosis drug, …

yahoo.com

4%
OFF

Why TG Therapeutics Stock Is Crushing It Today - Yahoo

2 weeks from now

Nov 1, 2023 · Shares of the biopharmaceutical company were soaring 36.4% higher as of 11:32 a.m. ET. Why were TG Therapeutics' Q3 results so good? CEO Michael Weiss said in the …

yahoo.com

9%
OFF

TG Therapeutics (NASDAQ:TGTX) Shares Down 2.9% - Time To …

2 weeks from now

Jan 6, 2025 · View Our Latest Stock Analysis on TG Therapeutics. TG Therapeutics Price Performance. The company's 50-day simple moving average is $31.26 and its 200-day simple …

marketbeat.com

60%
OFF

Why TG Therapeutics Stock Is Falling Today - Benzinga

2 weeks from now

Nov 30, 2021 · TGTX Price Action: TG Therapeutics has traded as high as $56.74 and as low as $21.05 over a 52-week period. The stock was down 41.60% at $13.65. TGTX TG …

benzinga.com

38%
OFF

Why TG Therapeutics Stock Was Rocketing Higher This Week

2 weeks from now

May 3, 2024 · Commercial-stage biotech TG Therapeutics (TGTX 0.38%) was having a fine week on the stock exchange, thanks in no small part to an investor-pleasing earnings report. It …

fool.com

82%
OFF

Why Is Tg Therapeutics Inc (TGTX) Stock Down 6.82% Today?

2 weeks from now

Jul 13, 2023 · Shares of Tg Therapeutics Pharmaceuticals (TGTX) dropped by 7.97% from $7.78 to $7.16 in the trading on Monday, October 9, 2023. The reason why TGTX stock down is due …

stockscan.io

$103
OFF

What's Going On With TG Therapeutics Stock Tuesday?

2 weeks from now

1 day ago · TG Therapeutics expects fourth-quarter BRIUMVI net product revenue in the U.S. to be $103.6 million. TG Therapeutics says it expects to report a 2024 year-end cash position of …

benzinga.com

40%
OFF

Why TG Therapeutics Is Plunging More Than 40% Today

2 weeks from now

Nov 30, 2021 · Why TG Therapeutics Stock Is Crashing Today. 3 Top Biotech Stocks Defying the Bear Market. 914%. Premium Investing Services. Invest better with The Motley Fool. Get stock …

fool.com

9%
OFF

Why TGTX Stock Is Rallying Today - MSN

2 weeks from now

The shares of drug maker TG Therapeutics (TGTX) are climbing 9% today after the firm preannounced higher-than-expected 2024 revenue from its multiple sclerosis drug, Briumvi. …

msn.com

FAQs about Why TG Therapeutics Stock Is Crashing Today - Yahoo Coupon?

Why did TG Therapeutics stock crash Monday?

TG Therapeutics stock crashed Monday after missing profit expectations, though sales of its multiple sclerosis treatment beat forecasts. TG Therapeutics (TGTX) delivered earnings and revenue surprises of -50% and 4.46%, respectively, for the quarter ended September 2024. ...

Why did TG Therapeutics stock rise Wednesday?

TG Therapeutics stock rose Wednesday after the company unveiled promising five-year test results for its multiple sclerosis drug, Briumvi. Stocks closed lower and at session lows in the stock market today after the Federal Reserve decided to cut short-term interest rates by half a point. ...

Why are TG Therapeutics (tgtx) shares climbing 9% today?

The shares of drug maker TG Therapeutics (TGTX) are climbing 9% today after the firm preannounced higher-than-expected 2024 revenue from its multiple sclerosis drug, Briumvi. Briumvi's 2024 Revenue Exceeded TG's Guidance The company estimated today that its 2024 revenue from the MS treatment had come in at $310 million. ...

Is TG Therapeutics (tgtx) a good stock to buy now?

TG Therapeutics (TGTX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term. ...

What happened to TG Therapeutics?

TG Therapeutics, despite its significant achievements, has also faced notable setbacks. The company's cancer drug Ukoniq was pulled from the market due to its ineffectiveness. ...

What happened to TG Therapeutics (tgtx) in Q2?

The drugmaker delivered a couple of surprises in Q2. Shares of TG Therapeutics ( TGTX -7.97%) were crashing 50.4% lower as of 11:12 a.m. ET on Tuesday. The huge sell-off came after the company announced its second-quarter results. Total net product revenue was $16 million in the second quarter. ...